Zobrazeno 1 - 10 of 53 pro vyhledávání: '"Karl M, Schrott"'
1
Organerhaltende Therapie des invasiven Harnblasenkarzinoms
Autor: J. Dunst, Christian Wittekind, C. Bornhof, R. Sauer, Karl M. Schrott, Altendorf-Hofmann A
Publikováno v: DMW - Deutsche Medizinische Wochenschrift. 117:1783-1788
With the aim of organ preservation, transurethral resection with subsequent radiotherapy (until 1985) or combined radio- and chemotherapy (since 1986) was undertaken as part of a prospective trial in 175 consecutive patients (137 men, 38 women; mean
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ee18361b174e82b2b61917a80257329e
https://doi.org/10.1055/s-2008-1062509
Zobrazit plný text záznamu
2
Combined-Modality Treatment and Organ Preservation in Bladder Cancer
Autor: Dirk G. Engehausen, Franz Rödel, Karl M. Schrott, Christian Weiss, Ina Wolf, Rolf Sauer, Claus Rödel, Thomas Papadopoulos
Publikováno v: Strahlentherapie und Onkologie. 181:213-222
In invasive bladder cancer, several groups have reported the value of organ preservation by a combined-treatment approach, including transurethral resection (TUR-BT) and radiochemotherapy (RCT). As more experience is acquired with this organ- sparing
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f43d3a053a64e1e50da060be7c10e609
https://doi.org/10.1007/s00066-005-1417-4
Zobrazit plný text záznamu
3
Clinical Aspects for the Use of DNA Image Cytometry in Detection of Bladder Cancer: A Valuable Tool?
Autor: Karl M. Schrott, Ziya Y. Akcetin, Karl-H. Bichler, Gerhard Feil, F. Steffen Krause
Publikováno v: DNA and Cell Biology. 22:721-725
The employment of DNA flow or image cytometry for oncological diagnostic procedures is favored because of its high correlation to tumor biological behavior. Prognostic statements and therapeutic strategies therefore are based on the high validity of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fbdad25a51e7440b5455f4c15e9ae6d
https://doi.org/10.1089/104454903770946692
Zobrazit plný text záznamu
4
Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy
Autor: William U. Shipley, Claus Rödel, Anthony L. Zietman, Karl M. Schrott, Juergen Dunst, Rolf Sauer
Publikováno v: Seminars in Surgical Oncology. 20:24-32
Organ preservation has been investigated in muscle-invasive bladder cancer over the past decades as an alternative to standard radical cystectomy. The results of large prospective protocols and population-based studies suggest that an organ-preservin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c05ba5f3bd5fa0b3218abca8fd09acf6
https://doi.org/10.1002/ssu.1013
Zobrazit plný text záznamu
5
Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation
Autor: Reinhard Kühn, Franz Rödel, Karl M. Schrott, Jürgen Dunst, Thomas Zörcher, Dominik Fürsich, Peter Martus, Gerhard G. Grabenbauer, Rolf Sauer, Claus Rödel, Thomas Papadopoulos, S. Birkenhake
Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 46:1213-1221
Purpose: Several groups have reported the value of bladder preservation by a combined treatment protocol, including transurethral resection (TUR-B) and radiochemotherapy (RCT). As more experience is acquired with organ-sparing treatment, patient sele
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f407bc44e43471a271c209555fa29609
https://doi.org/10.1016/s0360-3016(99)00544-1
Zobrazit plný text záznamu
7
Serotonin used as prognostic marker of urological tumors
Autor: Nina Jungwirth, Bernd Wullich, Karl M. Schrott, Frens S. Krause, Lothar Haeberle
Publikováno v: World journal of urology. 26(5)
In regard to therapy and prognosis of urological tumors, specific tumor markers are lacking especially in renal and urinary bladder carcinoma. Our study examines the relevance of serum serotonin levels to urinary bladder, prostate, renal, and testicu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2af8709f8f9d67e2e8cae4e25315af97
https://pubmed.ncbi.nlm.nih.gov/18581119
Zobrazit plný text záznamu
8
Radiotherapy with and without cisplatin in bladder cancer
Autor: Rolf Sauer, C. Bornhof, Karl M. Schrott, H. Fischer, Juergen Dunst, A. Altendorf-Hofmann
Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 19:687-691
From October 1985 to December 1988, 67 patients with invasive bladder carcinoma T1-4 N0-2 M0 were treated with irradiation (50.4 Gy in 28 fractions in 6 weeks) and simultaneous cisplatin (25 mg/m2 per day on 5 consecutive days in the first and fifth
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b801942e15e8d61de9b32dfccf9ab25
https://doi.org/10.1016/0360-3016(90)90497-8
Zobrazit plný text záznamu
10
Polymorphisms in the human progesterone receptor (PGR) gene of two human prostate adenocarcinoma cell lines
Autor: Dirk G, Engehausen, Sabine, Endele, Steffen F, Krause, Torsten, Rith, Karl M, Schrott, Ziya, Akcetin
Publikováno v: Anticancer research. 25(3A)
The incidence and mortality rate of prostate cancer has been steadily increasing in most countries worldwide. A potential implication of the progesterone receptor has been reported in prostatic carcinogenesis. In this study, an allele of human proges
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f2bed94ba2a097414a00498102deae2f
https://pubmed.ncbi.nlm.nih.gov/16033068
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje